Pfizer said Wednesday that its vaccine is now 95% effective in preventing COVID-19...
It's Main Street's Turn to Get Paid | | | It's no secret that Main Street investors are fighting an uphill battle against Wall Street's automatic trading machines.
These supercomputers can execute thousands of trades in a matter of seconds… triggering massive stock runs before you even have time to blink.
But that unfair advantage ends today.
Now YOU have an opportunity to make the same lightning-fast profits as the pros on Wall Street, thanks to a newly developed trading technology called Storm.
With Storm, you'll discover which stocks to get in on and precisely when to get out of them — completely automated. | | | | | Roger Scott | 20+ years of trading experience managed over $900 million teaching thousands daily. | | | | | Global Stocks Rise Following More COVID-19 Vaccine Data | | | | Global stock markets opened higher this morning after Pfizer Inc. (NYSE: PFE) said its COVID-19 vaccine is more effective than first advertised.
Pfizer said Wednesday that its vaccine is now 95% effective in preventing COVID-19, and that the company plans to submit the potential drug to U.S. regulators in just a matter of days.
But how long will it take us to get our hands on it? In today's video, you'll learn which two major reports are shaping the stock market this week… how long it'll take the market to assimilate a COVID-19 vaccine… whether large-cap stocks are overbought… why you should stay away from FANG stocks… and which two stocks you'll want to target right now. | | | | |
| November 15, 2020 | Global stock markets are higher this morning after a second COVID-19 vaccine showed promising results, even as new cases continue to surge around the globe. Moderna Inc (Nasdaq: MRNA), an American biotechnology company that focuses on drug development, said its coronavirus vaccine seems to be 94.5% effective. But like Pfizer Inc. (NYSE: PFE) stated last week, the drug is still in its preliminary stages. That means we have a long way to go, folks…
Continue Reading | | |
| November 14, 2020 | The stock market is like a shooting target… and here at WealthPress we're determined to hit a bullseye on every trade we place. And while we're no lousy shots, there are certain tricks we've had to learn to make our aim more accurate… bringing out the big guns while minimizing any shockwaves headed toward our trading accounts. That's why market expert Adam Sarhan is telling viewers about his new approach to trading the stock market.
Continue Reading | | | | |
0 Response to "Global Stocks Rise Following More COVID-19 Vaccine Data"
Post a Comment